E.N. Griep

805 total citations
12 papers, 648 citations indexed

About

E.N. Griep is a scholar working on Rheumatology, Psychiatry and Mental health and Immunology. According to data from OpenAlex, E.N. Griep has authored 12 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 5 papers in Psychiatry and Mental health and 3 papers in Immunology. Recurrent topics in E.N. Griep's work include Fibromyalgia and Chronic Fatigue Syndrome Research (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). E.N. Griep is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). E.N. Griep collaborates with scholars based in Netherlands, United States and Australia. E.N. Griep's co-authors include J. Boersma, E. R. de Kloet, J. K. van der Korst, Eef G.W.M. Lentjes, Fred P.H.T.M. Romijn, Maarten Boers, Dirkjan van Schaardenburg, Maaike Heslinga, Alexandre E. Voskuyl and Michael T. Nurmohamed and has published in prestigious journals such as Annals of the Rheumatic Diseases, Psychoneuroendocrinology and Arthritis & Rheumatology.

In The Last Decade

E.N. Griep

10 papers receiving 605 citations

Peers

E.N. Griep

PMH

PHARM

PHYSI

Isabelle Gaumond Canada

Tamara E. Lacourt United States

Diana Kadetoff Sweden

Susan Pelton United States

Kate L. Holliday United Kingdom

G Mennuni Italy

Yolanda Rebeca Peñaloza López Mexico

Ferran J Garcia-Fructuoso Spain

Emma Guymer Australia

B. Minner Belgium

Isabelle Gaumond Canada

E.N. Griep

212 ×0.5

PMH

299 ×1.3

PHARM

63 ×0.3

412 ×4.2

PHYSI

33 ×0.4

Citations per year, relative to E.N. Griep E.N. Griep (= 1×) peers Isabelle Gaumond

Countries citing papers authored by E.N. Griep

Since Specialization

Citations

This map shows the geographic impact of E.N. Griep's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.N. Griep with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.N. Griep more than expected).

Fields of papers citing papers by E.N. Griep

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.N. Griep. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.N. Griep. The network helps show where E.N. Griep may publish in the future.

Co-authorship network of co-authors of E.N. Griep

This figure shows the co-authorship network connecting the top 25 collaborators of E.N. Griep. A scholar is included among the top collaborators of E.N. Griep based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.N. Griep. E.N. Griep is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Boheemen, Laurette van, Samina A. Turk, Wouter H Bos, et al.. (2020). AB0230 STATINS TO PREVENT RHEUMATOID ARTHRITIS: INCONCLUSIVE RESULTS OF THE STAPRA TRIAL. Annals of the Rheumatic Diseases. 79. 1415–1416. 2 indexed citations

Boheemen, Laurette van, Samina A. Turk, Wouter H Bos, et al.. (2019). AB0286 STATINS TO PREVENT RHEUMATOID ARTHRITIS (STAPRA TRIAL): CHALLENGES IN RECRUITMENT AND RETENTION. Annals of the Rheumatic Diseases. 78. 1600–1601. 3 indexed citations

Heslinga, Maaike, E.N. Griep, Maarten Boers, et al.. (2019). Suboptimal cardiovascular risk management in rheumatoid arthritis patients despite an explicit cardiovascular risk screening programme. Scandinavian Journal of Rheumatology. 48(5). 345–352. 18 indexed citations

Tran‐Duy, An, Martijn A. H. Oude Voshaar, Harald E. Vonkeman, et al.. (2018). An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity. Arthritis & Rheumatology. 70(10). 1557–1564. 17 indexed citations

Heslinga, Maaike, E.N. Griep, Yvo M. Smulders, et al.. (2017). SAT0114 Poor cardiovascular risk management in rheumatoid arthritis patients despite an explicit cardiovascular risk management program. Annals of the Rheumatic Diseases. 76. 811–812.

Heslinga, S.C., Michael T. Nurmohamed, A. Gerards, et al.. (2016). SAT0416 Significantly Reduced Recurrence Rate of Acute Anterior Uveitis in Ankylosing Spondylitis during Treatment with Golimumab. Annals of the Rheumatic Diseases. 75. 820–821.

Griep, E.N., et al.. (1998). Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain.. PubMed. 25(7). 1374–81. 215 indexed citations

Lentjes, Eef G.W.M., et al.. (1997). Glucocorticoid receptors, fibromyalgia and low back pain. Psychoneuroendocrinology. 22(8). 603–614. 79 indexed citations

Jacobs, Johannes W G, Johannes J. Rasker, & E.N. Griep. (1995). Fibromyalgia: a stress related neuro-endocrine disorder? A hypothetical framework on the aetiology and perseverance of the syndrome. University of Twente Research Information. 24(2). 274–276. 1 indexed citations

10.

Griep, E.N., J. Boersma, & E. R. de Kloet. (1994). Pituitary release of growth hormone and prolactin in the primary fibromyalgia syndrome.. PubMed. 21(11). 2125–30. 48 indexed citations

11.

Griep, E.N., J. Boersma, & E. R. de Kloet. (1993). Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome.. PubMed. 20(3). 469–74. 261 indexed citations

12.

Griep, E.N., Michele C. Zee, & G.J.H. den Ottolander. (1990). Determination of plasminogen activator inhibitor in human plasma and blood platelets and its clinical relevance. Fibrinolysis and Proteolysis. 4. 141–144. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact